Brief: Annexin Pharmaceuticals Raises SEK 35.6 Million From Rights Issue

Annexin Pharmaceuticals AB (publ)

19/12/2023 07:27

Dec 19 (Reuters) - Annexin Pharmaceuticals AB  ANNX.ST :
    * SAID ON MONDAY IT ANNOUNCES OUTCOME OF RIGHTS ISSUE AND
RESOLVES
ON DIRECTED ISSUES TO GUARANTORS AND LENDERS
    * THROUGH RIGHTS ISSUE, COMPANY RECEIVES ABOUT SEK 35.6
MILLION
BEFORE ISSUE RELATED COSTS
    * SUBSCRIPTION RATE AT ABOUT 127.1%
    * RESOLVED ON DIRECTED ISSUE OF 5.4 MLN SHARES TO GUARANTORS
IN
RIGHTS ISSUE
    * SUBSCRIPTION PRICE IN DIRECTED ISSUES IS SET TO 0.28 SEK
PER
SHARE

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nMFN7q36qt
 Further company coverage:  ANNX.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))